Tag: Cancer: Rectal
CRC Screening Recommended for Average-Risk Adults Age 50 to 75
CRC screening test should be selected based on discussion of benefits, harms, costs with patients
Personal Colorectal Cancer Risk Should Drive Screening
Panel issues weak recommendations for options in adults aged 50 to 79 years with no prior screening
Prediagnostic Colonoscopy Cuts Colorectal Cancer Death Risk
Mortality risk drops 17 percent with one colonoscopy before diagnosis, 45 percent with three colonoscopies
Triplet Tx Ups Survival in BRAF V600E-Mutated Colorectal Cancer
Overall survival longer for encorafenib, cetuximab, and binimetinib combo versus standard therapy
Low Cancer Suspicion Tied to Delay in CRC Referral in Primary Care
Presentation without alarm symptoms linked to long duration to referral in multivariable analysis
High-Intensity Surveillance of Colorectal Adenomas Modeled
Model shows high-intensity surveillance could provide modest, clinically relevant benefits at acceptable cost
Colorectal Cancer Mortality Disparities Vary Across U.S. Cities
Racial disparities in 25 of 30 cities examined; highest disparity in Washington, D.C., lowest in Philadelphia
Incidence of Colorectal Cancer Up in Younger Adults Worldwide
In most high-income countries with long-term data, uptick in early-onset disease began in mid-1990s
Physical Activity, Overall Survival Not Linked in Metastatic CRC
Nine or more MET hours per week tied to lower risk for grade ≥3 treatment-related adverse events
Oral Antibiotic Use Linked to Risk for Colorectal Cancer
Risk for colon cancer increased, risk for rectal cancer reduced in association with oral antibiotic use
